To make measuring units easier, connection which is wireless has been configured between smartphone and potentiostat called NFC interface that makes the potentiostat into passive operated device running without battery. Using amperometric detection, the hepatitis B antigen (HBsAg) was qualified with the ...
HBV causes acute and chronic hepatitis B; chronic HBV infection puts more than 250 million virus carriers at a greatly increased risk to develop terminal liver disease, i.e., liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [1]. While an effective prophylact...
A smartphone-controlled electrochemical sensor operated entirely via Near Field Communication (NFC) was used to create a simple label-free immunoassay for detecting Hepatitis B Virus (HBV). The completed system was composed of a card-sized electrochemical NFC tag sensor integrated with a smartphone ...
Porphyria cutanea tarda and hepatitis B and C viruses replication. Evaluation of alpha-interferon therapydoi:10.1016/S0168-8278(05)80886-4ELSEVIERJournal of Hepatology
Background: A pre-vaccination survey conducted before introduction of universal hepatitis B immunisation in South Africa reported HBsAg carriage of 8.1% in 0-6 months old, 12.8% in 3-year-olds, and an increase to 15.7% by the age of 6 years. However, no studies investigated pre-vaccination...
Hepatitis C Mortality Trends in San Francisco: Can We Reach Elimination Targets?Ali Mirzazadeh MD, MPH, PhD a bShelley N. Facente MPH, PhD c fKatie Burk MPH dJames G. Kahn MD, MPH eMeghan D. Morris PhD, MPH a b fEnd Hep C SF...
A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice. Immunol. Lett. 2015, 168, 293–299. [CrossRef] [PubMed] 29. Li, J.Q.; Ge, J.; Ren, S.L.; Zhou, T.; Sun, Y....
Keywords: hepatitis B; immune tolerant; hepatocellular carcinoma; cirrhosis; vaccine; inflammation 1. Introduction Hepatitis B virus (HBV) replicates in hepatocytes. Elevated hepatocyte turnover during HBV infection is thought to be mostly attributable, directly and indirectly, to the adaptive immune ...
HBV causes acute and chronic hepatitis B; chronic HBV infection puts more than 250 million virus carriers at a greatly increased risk to develop terminal liver disease, i.e., liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [1]. While an effective prophylactic vaccine is available ...
Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J. Gastroenterol. 2003, 38, 244–253. [CrossRef] [PubMed] 29. Geoghegan, J.L.; Di Giallonardo, F.; Cousins, K.; Shi, M.; Williamson, J.E.; Holmes, E.C. Hidden diversity...